Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep;142(3):e20180458.
doi: 10.1542/peds.2018-0458. Epub 2018 Aug 13.

Legislation to Increase Uptake of HPV Vaccination and Adolescent Sexual Behaviors

Affiliations

Legislation to Increase Uptake of HPV Vaccination and Adolescent Sexual Behaviors

Erin E Cook et al. Pediatrics. 2018 Sep.

Abstract

Background: Despite preventive health benefits of the human papillomavirus (HPV) vaccination, uptake in the United States remains low. Twenty-four states have enacted legislation regarding HPV vaccination and education. One reason these policies have been controversial is because of concerns that they encourage risky adolescent sexual behaviors. Our aim in this study is to determine if state HPV legislation is associated with changes in adolescent sexual behaviors.

Methods: This is a difference-in-difference study in which we use data on adolescent sexual behaviors from the school-based state Youth Risk Behavior Surveillance System from 2001 to 2015. Sexual behaviors included ever having sexual intercourse in the last 3 months and condom use during last sexual intercourse. We compared changes in sexual behaviors among high school students before and after HPV legislation to changes among high school students in states without legislation.

Results: A total of 715 338 participants reported ever having sexual intercourse in the last 3 months, and 217 077 sexually active participants reported recent condom use. We found no substantive or statistically significant associations between HPV legislation and adolescent sexual behaviors. Recent sexual intercourse decreased by 0.90 percentage points (P = .21), and recent condom use increased by 0.96 percentage points (P = .32) among adolescents in states that enacted legislation compared with states that did not. Results were robust to a number of sensitivity analyses.

Conclusions: Implementation of HPV legislation was not associated with changes in adolescent sexual behaviors in the United States. Concern that legislation will increase risky adolescent sexual behaviors should not be used when deciding to pass HPV legislation.

PubMed Disclaimer

Conflict of interest statement

POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Adolescent sexual behaviors over time in states with HPV legislation and states without HPV legislation. A, Sexual intercourse during the last 3 months. B, Condom use during last sexual intercourse. In A, we show the percentage of adolescents ever having sexual intercourse over the last 3 months for states that passed HPV legislation (solid black line) and states that did not pass HPV legislation (dashed black line). In B, we show the percentage of adolescents using condoms the last time they had sexual intercourse for states that passed HPV legislation (solid black line) and states that did not pass HPV legislation (dashed black line). Most states that passed HPV legislation did so in 2007. The first HPV vaccination was approved by the US Food and Drug Administration in 2006.

Similar articles

Cited by

References

    1. Satterwhite CL, Torrone E, Meites E, et al. . Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013;40(3):187–193 - PubMed
    1. Centers for Disease Control and Prevention Sexually Transmitted Disease Surveillance 2014. Atlanta, GA: US Department of Health and Human Services; 2015
    1. Food and Drug Administration June 8, 2006 Approval Letter - Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant. Rockville, MD: Department of Health and Human Services; 2006. Available at: http://wayback.archive-it.org/7993/20170722145339/https://www.fda.gov/Bi.... Accessed July 7, 2018
    1. Food and Drug Administration October 16, 2009 Approval Letter - Cervarix. Rockville, MD: Department of Health and Human Services; 2009. Available at: http://wayback.archive-it.org/7993/20170723025640/https://www.fda.gov/Bi.... Accessed July 7, 2018
    1. Food and Drug Administration December 10, 2014 Approval Letter - GARDASIL 9. Rockville, MD: Department of Health and Human Services; 2014. Available at: https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm.... Accessed July 7, 2018

Publication types

MeSH terms

Substances